Regarding CCL2 (Figure 3B), increased expression correlates with higher risk in kidney renal papillary cell carcinoma (KIRP) and low-grade glioma (LGG), indicating its role as a negative prognostic marker for these malignancies. This evidence concerns the gene CCL2 and central nervous system cancer.